Document is current
Any future updates will be listed below
-
Authors
Fanelli, Giuseppe https://orcid.org/0000-0001-7930-563X
Franke, Barbara https://orcid.org/0000-0003-4375-6572
Fabbri, Chiara https://orcid.org/0000-0003-0276-7865
Werme, Josefin https://orcid.org/0000-0001-5015-2078
Erdogan, Izel
De Witte, Ward
Poelmans, Geert https://orcid.org/0000-0001-7039-6985
Ruisch, I. Hyun
Reus, Lianne Maria https://orcid.org/0000-0001-6936-242X
van Gils, Veerle https://orcid.org/0000-0001-8240-5367
Jansen, Willemijn J.
Vos, Stephanie J. B.
Alam, Kazi Asraful
Martinez, Aurora https://orcid.org/0000-0003-1643-6506
Haavik, Jan https://orcid.org/0000-0001-7865-2808
Wimberley, Theresa
Dalsgaard, Søren https://orcid.org/0000-0003-4659-0969
Fóthi, Ábel https://orcid.org/0000-0001-7398-9700
Barta, Csaba https://orcid.org/0000-0002-4350-8838
Fernandez-Aranda, Fernando https://orcid.org/0000-0002-2968-9898
Jimenez-Murcia, Susana
Berkel, Simone https://orcid.org/0000-0002-5134-2217
Matura, Silke
Salas-Salvadó, Jordi https://orcid.org/0000-0003-2700-7459
Arenella, Martina
Serretti, Alessandro https://orcid.org/0000-0003-4363-3759
Mota, Nina Roth https://orcid.org/0000-0003-3504-759X
Bralten, Janita https://orcid.org/0000-0003-1440-8675
- License Information
-
More Information
Article History
Received: 25 July 2024
Revised: 14 March 2025
Accepted: 24 March 2025
First Online: 12 April 2025
Competing interests
: AS is or has been a consultant/speaker for Abbott, Abbvie, Angelini, AstraZeneca, Clinical Data, Boehringer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Innovapharma, Italfarmaco, Janssen, Lundbeck, Naurex, Pfizer, Polifarma, Sanofi, Servier, and Taliaz. BF discloses having received educational speaking fees and travel support from Medice. CF was a speaker for Janssen. GP is director/chief scientific officer and WDW as well as IHR are employees of Drug Target ID, Ltd., but their activities at this company do not constitute competing interests with regard to this paper. JH has received lecture honoraria as part of continuing medical education programs sponsored by Shire, Takeda, Medice, and Biocodex. JSS reported receiving research support through his institution from the Patrimonio Comunal Olivarero, Almond Board of California and Pistachio Growers of California; he is serving on the board of and receiving grant support through his institution from the International Nut and Dried Foundation, Instituto Danone Spain and Institute Danone International. FFA and SJM have been consultants/speakers for NovoNordisk. All other authors report no biomedical financial interests or potential conflicts of interest.
: We used publicly available summary statistics of genome-wide association studies (GWASs) conducted by external authors and consortia; thus, no specific authorisation was required from the local Ethics Committee. No individual genotypic data were used or collected.
